ATF4 and lung carcinoma: Furthermore, an additional study revealed that fluoxetine hinders lung cancer progression through activation of the ATF4-AKT-mTOR signaling pathway, inducing cell cycle arrest and autophagy to impede cancer cell proliferation without affecting normal lung epithelial cell proliferation (46).